Loading...

  1. v3.6.1.781iOS
    2025 Edition Content Update
  2. v3.6.1.776Android
    2025 Edition Content Update
  3. v3.5.0.767iOS
    Content update
  4. v3.4.1.748iOS
    Content update
  5. v3.3.0.712iOS
    Added audio pronunciations
  6. v3.2.2.691iOS
    Updated UI
    New notes feature
    Added news feed
    Provides second free trial for returning users
  7. v3.1.3.617iOS
    Updated UI
    New notes feature
    Added news feed
  8. v3.0.1.520iOS
    Framework update
  9. v2.6.3.439iOS
    Updated Mailchimp config
  10. v2.6.2.437iOS
    Bug fixes made to Universal Links
  11. v2.6.0.411iOS
    Latest data update bundled.
  12. v2.5.1.333iOS
    2018 content update
    Minor styling improvements
  13. v2.4.2.299iOS
    New implementation for 30-day free trial
  14. v2.3.0.272iOS
    Improved user feedback
  15. v2.2.1.251iOS
    Updated analytics
  16. v2.1.1.240iOS
    - Bundled updated data
    - Updated icon, splash screen and styling
  17. v1.2.1.112iOS
    New drug entries: albiglutide (Tanzeum), apremilast (Otezla), dalbavancin (Dalvance), dapagliflozin (Farxiga), dulaglutide (Trulicity), empagliflozin (Jardiance), eslicarbazepine acetate (Aptiom), ferric citrate (Auryxia), insulin, inhaled (rapid acting) (Afrezza), naloxegol (Movantik), olodaterol (Striverdi Respimat), omega 3-carboxylic acids (Epanova), oritavancin (Orbactiv), sucroferric oxyhydroxide (Velphoro), suvorexant (Belsomra), tedizolid (Sivextro), umeclidinium (Incruse Ellipta), vedolizumab (Entyvio), and vorapaxar (Zontivity).
  18. v1.0.6.28iOS
    Various minor bug fixes and performance improvements

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Nurse's Drug Handbook, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0